Position in PRLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$37,309,655
+$5,672,813 QoQ
Shares Held
10,909,256
0.0% QoQ
Ownership
13.7%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PRLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. PRLD ranks #23 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $488,832,498 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
7,959,538 | $312,013,889 | |
| 3 | SION |
Sionna Therapeutics, Inc.
|
3,530,702 | $141,545,843 | |
| 4 | MBX |
MBX Biosciences, Inc.
|
3,637,887 | $108,590,926 | |
| 5 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $104,824,037 | |
| 6 | ARGX |
Argenx SE
|
136,900 | $99,971,225 | |
| 7 | CMPX |
Compass Therapeutics, Inc.
|
15,219,994 | $80,513,768 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,475,403 | $71,114,424 |
All Filings in PRLD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-04-21 | $59,760,028 | 12,935,071 | Shares | Sole | 2026-04-23 | |
| 2026-03-31 | $37,309,655 | 10,909,256 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $31,636,842 | 10,909,256 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,709,328 | 10,909,256 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,825,588 | 10,909,256 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,378,308 | 10,909,256 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,909,301 | 10,909,256 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,582,159 | 10,909,256 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $41,564,265 | 10,909,256 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $51,709,873 | 10,909,256 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $46,582,523 | 10,909,256 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $33,709,601 | 10,909,256 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $49,091,652 | 10,909,256 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $57,226,238 | 10,039,691 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $60,639,733 | 10,039,691 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $66,362,357 | 10,039,691 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $52,407,187 | 10,039,691 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $69,273,867 | 10,039,691 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $124,994,152 | 10,039,691 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $313,740,343 | 10,039,691 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $287,436,353 | 10,039,691 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $435,019,811 | 10,039,691 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,115,813,449 | 15,594,877 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $469,873,644 | 15,594,877 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||